Prosthetic Foot Adaptability for Amputation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how different designs of prosthetic feet can enhance daily life for individuals with lower extremity amputations. Participants will test both a locked and an unlocked version of a new foot prosthesis, the META-Arc foot, to evaluate which offers better comfort, mobility, and ease in daily activities. The study will compare these new designs to each participant's usual prosthetic foot. The trial seeks individuals who have had an amputation for at least one year, use a prosthesis, and can walk over 400 meters without increased pain. As an unphased trial, it offers participants the chance to contribute to innovative research that could advance prosthetic technology and improve quality of life for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on prosthetic foot use, so it's best to discuss your medications with the trial team.
What prior data suggests that this prosthetic foot is safe for people with lower extremity amputation?
Research has shown that the META-Arc prosthetic foot, in both its locked and unlocked versions, offers promising safety features based on mechanical testing. These tests revealed that the foot's design facilitates smooth side-to-side movement, which can reduce sideways forces and may lower the risk of falls or discomfort for users.
The META-Arc's ankle joint rotates side to side, similar to a natural human ankle, enhancing balance and comfort for individuals with lower-limb amputations. The locked version restricts this movement, providing a more stable option for those who need it.
Overall, studies suggest that both versions of the META-Arc foot enhance safety and comfort by reducing stress and increasing stability. However, as this is a new prosthetic foot, ongoing research and user feedback remain important to fully understand its safety in everyday use.12345Why are researchers excited about this trial?
Researchers are excited about the META-Arc foot treatments because they offer innovative approaches to prosthetic foot adaptability for amputees. Unlike standard prosthetic feet, these treatments focus on adjustable ankle articulation, providing users with either locked or unlocked options. The unlocked condition allows for 20 degrees of frontal plane ankle motion, which could enhance natural movement and adaptability. Meanwhile, the locked condition eliminates this motion, potentially offering more stability. These options might lead to improved comfort and mobility for users, addressing varying needs in different situations.
What evidence suggests that the META-Arc foot is effective for improving mobility in people with lower extremity amputation?
Research has shown that the META-Arc prosthetic foot can improve balance and movement for people with leg amputations. In this trial, participants will join different arms to test the effectiveness of two versions of the META-Arc foot. The unlocked version, available to participants in one arm, allows for 20 degrees of movement, mimicking a natural ankle and reducing sideways pressure. This flexibility aids balance and eases walking. Meanwhile, the locked version, available to participants in another arm, limits side-to-side movement but still uses a special ankle joint to enhance stability. Both versions aim to make walking more comfortable and daily activities easier for users.12346
Who Is on the Research Team?
Murray Maitland, PT, PhD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for individuals with above-knee amputations, bilateral amputations, or below-knee amputations who have lower mobility levels. It aims to help them with balance, pain, and daily activities by testing a new type of foot prosthesis.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
A1 Phase
Participants use their usual prosthetic foot and complete baseline assessments
B1 Phase
Participants use the investigational foot with either locked or unlocked linkage and perform community activities
B2 Phase
Participants continue using the investigational foot with the opposite linkage condition and perform community activities
A2 Phase
Participants return to using their usual prosthetic foot and reflect on differences
Follow-up
Participants are monitored for safety and effectiveness after the trial phases
What Are the Treatments Tested in This Trial?
Interventions
- META-Arc foot locked
- META-Arc foot unlocked
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
United States Department of Defense
Collaborator